Literature DB >> 24591529

Binding of prorenin to (pro)renin receptor induces the proliferation of human umbilical artery smooth muscle cells via ROS generation and ERK1/2 activation.

Feng Y Liu1, Xiao Y Liu1, Li J Zhang1, Yun P Cheng2, Yi N Jiang3.   

Abstract

INTRODUCTION: Since the discovery of the (pro)renin receptor (PRR), it has been considered as a novel bioactive molecule of the renin-angiotensin system (RAS). The activation of PRR can elicit a series of angiotensin II (AngII)-independent effects.
MATERIALS AND METHODS: In this study, we investigated the effects of prorenin and PRR on the proliferation of human umbilical artery smooth muscle (HUASM) cells and explored the possible mechanisms underlying these effects.
RESULTS: The binding of prorenin to PRR can promote proliferation and upregulate the anti-apoptotic protein Bcl-2 and downregulate the pro-apoptotic protein Bax independently of AngII in HUASM cells. In addition, the binding of prorenin to PRR can also increase the production of reactive oxygen species (ROS) and the phosphorylation of extracellular signal-regulated kinase (ERK1/2) independently of AngII. The pretreatment of HUASM cells with an NADPH oxidase inhibitor DPI decreased the production of ROS and also decreased the phosphorylation of ERK1/2. Furthermore, pretreatment of HUASM cells with DPI and the ERK1/2 inhibitor PD98059 significantly attenuated the prorenin-induced proliferation and regulation of apoptosis factors.
CONCLUSION: Binding of prorenin to PRR can induce HUASM cell proliferation via the ROS generation and ERK1/2 activation.
© The Author(s) 2014.

Entities:  

Keywords:  (pro)renin receptor; ROS; apoptosis; atherosclerosis; proliferation

Mesh:

Substances:

Year:  2014        PMID: 24591529     DOI: 10.1177/1470320314525215

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  5 in total

1.  (Pro)renin receptor activation increases profibrotic markers and fibroblast-like phenotype through MAPK-dependent ROS formation in mouse renal collecting duct cells.

Authors:  Alexis A Gonzalez; Leonardo Zamora; Cristian Reyes-Martinez; Nicolas Salinas-Parra; Nicole Roldan; Catherina A Cuevas; Stefanny Figueroa; Alex Gonzalez-Vergara; Minolfa C Prieto
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-08-30       Impact factor: 2.557

Review 2.  Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.

Authors:  Feby Savira; Ruth Magaye; Danny Liew; Christopher Reid; Darren J Kelly; Andrew R Kompa; S Jeson Sangaralingham; John C Burnett; David Kaye; Bing H Wang
Journal:  Br J Pharmacol       Date:  2020-05-13       Impact factor: 8.739

3.  Inhibiting (pro)renin receptor-mediated p38 MAPK signaling decreases hypoxia/reoxygenation-induced apoptosis in H9c2 cells.

Authors:  Yan Liu; Shenglin Zhang; Dechun Su; Jinqiu Liu; Yunpeng Cheng; Lu Zou; Wenqiang Li; Yinong Jiang
Journal:  Mol Cell Biochem       Date:  2015-02-25       Impact factor: 3.396

Review 4.  Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease.

Authors:  Stella Bernardi; Andrea Michelli; Giulia Zuolo; Riccardo Candido; Bruno Fabris
Journal:  J Diabetes Res       Date:  2016-08-29       Impact factor: 4.011

5.  AVE0991, a Nonpeptide Angiotensin 1-7 Receptor Agonist, Improves Glucose Metabolism in the Skeletal Muscle of Obese Zucker Rats: Possible Involvement of Prooxidant/Antioxidant Mechanisms.

Authors:  Viktoria Dobrocsyova; Miroslava Slamkova; Katarina Krskova; Lucia Balazova; Maciej Suski; Rafal Olszanecki; Sona Cacanyiova; Stefan Zorad
Journal:  Oxid Med Cell Longev       Date:  2020-01-27       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.